People Who Inject Drugs
Cross-source consensus on People Who Inject Drugs from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Other
Other
Other
Highlighted claims
- People who inject drugs are disproportionately affected by hepatitis C. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
- Eligible participants are treatment-naive adults attending needle and syringe programme referral sites or people who self-report ever injecting drugs. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
- Up to two-fifths of new hepatitis C infections occur among people who inject drugs. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
- Community members from the study countries reviewed participant, recruitment, and education materials. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol
- Peer workers are involved in recruitment in some settings. — Non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia and Tanzania: a CUTTS HepC study protocol